One hour effects of salbutamol and formoterol on blood pressure, heart rate and oxygen saturation in asthmatics;Efeitos do salbutamol e do formoterol sobre pressão arterial, frequência cardíaca e saturação de oxigénio em asmáticos, durante uma hora

Revista Portuguesa de Pneumologia

Volumn 14, Issue 3, 2008, Pages 353-361

  Capuchinho Júnior, Geraldo Andrade ^a   Dias, Ricardo Marques ^a,b,c   Carvalho, Sônia Regina Silva ^a  

^a FEDERAL UNIVERSITY OF THE STATE OF RIO DE JANEIRO   (Brazil)

^b HOSPITAL UNIVERSITÁRIO GAFFRÉE E GUINLE   (Brazil)

^c Unidade Cardiopulmonar ^*  (Brazil)

Author keywords

Asthma; Blood pressure; Bronchodilator agents adverse effects; Heart rate; Oxygen saturation

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; FORMOTEROL; LONG ACTING DRUG; SALBUTAMOL; SHORT ACTING DRUG;

ADULT; ARTICLE; ASTHMA; BLOOD PRESSURE; BRONCHODILATATION; CLINICAL ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DIASTOLIC BLOOD PRESSURE DISORDER; DISEASE SEVERITY; DRUG EFFECT; FEMALE; FORCED EXPIRATORY VOLUME; HEART DISEASE; HEART HEMODYNAMICS; HEART RATE; HEART RATE DISORDER; HEMODYNAMICS; HUMAN; MALE; OUTPATIENT; OXYGEN SATURATION; PARTIAL OXYGEN SATURATION DISORDER; PEAK EXPIRATORY FLOW; PREVALENCE; SIDE EFFECT; STATISTICAL SIGNIFICANCE; SYSTOLIC BLOOD PRESSURE; SYSTOLIC BLOOD PRESSURE DISORDER;

EID: 45249115295     PISSN: 08732159     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0873-2159(15)30243-9     Document Type: Article

References (14)

1. SBPT. III Consenso Brasileiro de Asma. J Bras Pneumol 2002;28(1):S1-S28.
2. Hang HP, Dale MM, Ritter JM, Moore PK. Farmacologia. 5 ed. Rio de Janeiro: Elsevier, 2003.
3. Tranfa CME, Pelaia G, Grembiale RD, Naty S, Durante S, Borrello G. Short-term cardiovascular effects of salmeterol. Chest. 1998;113(5):1272-6.
4. Burggraaf J, Westendorp RG, in't Veen J, Schoemaker R, Sterk P, Cohen A, et al. Cardiovascular side effects of inhaled salbutamol in hypoxic asthmatic patients. Thorax 2001;56(7):567-9.
5. Global Initiatve for Asthma. Workshop report, global strategy for asthma management and prevention. Update 2005. www.ginasthma.com/
6. Sociedade Brasileira de Pneumologia e Tisiologia. Diretrizes para testes de funçáo pulmonar. J Bras Pneumol 2002;28(supl 3):S1-S238.
7. ATS/ERS Task Force: Standardization of lung function testing: Standardization of spirometry. Eur Respir J 2005; 26:319-38.
8. ATS/ERS Task Force: Standardization of lung function testing. Interpretative strategies for lung function tests. Eur Respir J 2005; 26:948-68.
9. Knudson R J, Lebowitz M D, Holberg C J, Burrows B. Changes in the normal maximal expiratory flow volume curve with growth and aging. Am Rev Respir Dis 1983; 127:725-34.
10. Siegel S, Castellan Jr NJ. Nonparametric statistics for the behavioral sciences. 2 ed. New York: McGraw-Hill, 1998.
11. Guhan AR, Cooper S, Oborne J, Lewis S, Bennett J, Tattersfield AE. Systemic effects of formoterol and salmeterol: a dose-response comparison in healthy subjects. Thorax 2000;55(8):650-6.
12. Eryonucu B, Uzun K, Güler N, Tuncer M, Sezgi C. Comparison of the Short-term Effects of Salmeterol and Formoterol on Heart Rate Variability in Adult Asthmatic Patients. Chest 2005;128(3):1136-9.
13. Kallergis EM, Manios EG, Kanoupakis EM, Schiza SE, Mavrakis HE, Klapsinos NK, Vardas PE. Acute electrophysiologic of inhaled salbutamol in humans. Chest 2005; 127:2057-63.
14. Salpeter SR, Buckley NS, Ormiston TM, Salpeter EE. Meta-analyses. Effect of long-acting beta agonist on severe asthma exacerbations and asthma-related deaths. Ann Intern Med 2006;144:904-12.